Medicus Pharma Ltd.
MDCX•NASDAQ•Healthcare•Drug Manufacturers - General

About Medicus Pharma

Medicus Pharma Ltd., a biotech/life sciences company, focuses on developing clinical development programs of therapeutic assets in the United States. It is developing SKNJCT-003, which is in Phase 2 study for the treatment of basal cell carcinoma of the skin. Medicus Pharma Ltd. has a strategic collaboration with the Gorlin Syndrome Alliance to access to SKINJECT in Patients with Gorlin Syndrome. The company was formerly known as Interactive Capital Partners Corporation and changed its name to Medicus Pharma Ltd. in September 2023. The company was incorporated in 2008 and is headquartered in Conshohocken, Pennsylvania.

Stock Details

ExchangeNASDAQ (NASDAQ)
CurrencyUSD - USD
TypeStock

Contact Information

Websitemedicuspharma.com
Phone610 540 7515
Address
300 Conshohocken State Road, Suite 200 Conshohocken, Pennsylvania 19428 United States

Corporate Identifiers

CIK0001997296
ISINCA58471K2020
EIN98-1778211
SIC2834

Leadership Team & Key Executives

Dr. Edward J. Brennan Jr., F.A.C.S., M.D.
Chief Scientific Officer and Head of Research & Development Program
Andrew Alasdair Smith
Chief Operating Officer
Anna Baran-Djokovic J.D.
Senior Vice President of Investor Relations
Viktoria Slepeniuk
Senior Vice President of Public Relations
Dr. Faisal Mehmud M.D.
Chief Medical Officer
Maryann Adesso
Chief of Staff and Corporate Secretary